Apyx Historical Balance Sheet

APYX Stock  USD 1.44  0.01  0.69%   
Trend analysis of Apyx Medical balance sheet accounts such as Short Long Term Debt Total of 40.4 M, Other Current Liabilities of 9.2 M or Total Current Liabilities of 13.4 M provides information on Apyx Medical's total assets, liabilities, and equity, which is the actual value of Apyx Medical to its prevalent stockholders. By breaking down trends over time using Apyx Medical balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Apyx Medical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Apyx Medical is a good buy for the upcoming year.

Apyx Medical Inventory

5.31 Million

  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Apyx Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
For more information on how to buy Apyx Stock please use our How to Invest in Apyx Medical guide.

About Apyx Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Apyx Medical at a specified time, usually calculated after every quarter, six months, or one year. Apyx Medical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Apyx Medical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Apyx currently owns. An asset can also be divided into two categories, current and non-current.

Apyx Medical Balance Sheet Chart

At this time, Apyx Medical's Non Current Liabilities Total is fairly stable compared to the past year. Other Current Assets is likely to rise to about 2.9 M in 2024, whereas Total Stockholder Equity is likely to drop slightly above 24.4 M in 2024.

Total Assets

Total assets refers to the total amount of Apyx Medical assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Apyx Medical books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Apyx Medical balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Apyx Medical are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.
Most accounts from Apyx Medical's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Apyx Medical current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Apyx Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
For more information on how to buy Apyx Stock please use our How to Invest in Apyx Medical guide.At this time, Apyx Medical's Non Current Liabilities Total is fairly stable compared to the past year. Other Current Assets is likely to rise to about 2.9 M in 2024, whereas Total Stockholder Equity is likely to drop slightly above 24.4 M in 2024.
 2021 2022 2023 2024 (projected)
Short and Long Term Debt Total305K796K38.5M40.4M
Total Assets68.7M51.8M79.2M83.2M

Apyx Medical balance sheet Correlations

0.30.570.820.810.320.19-0.60.150.670.82-0.110.420.940.66-0.45-0.050.740.320.110.770.780.50.41.00.71
0.30.290.38-0.3-0.01-0.40.31-0.70.50.40.110.70.20.21-0.22-0.26-0.031.00.190.330.480.960.310.280.24
0.570.290.810.320.13-0.07-0.12-0.420.80.37-0.240.580.360.86-0.230.180.610.320.380.570.820.50.250.580.61
0.820.380.810.530.230.09-0.54-0.270.950.82-0.230.570.660.89-0.310.140.710.40.210.850.880.620.360.830.71
0.81-0.30.320.530.330.43-0.770.630.290.55-0.14-0.040.840.45-0.310.060.73-0.29-0.020.520.44-0.10.230.820.54
0.32-0.010.130.230.330.25-0.320.00.260.260.760.280.130.3-0.7-0.750.610.00.710.370.390.070.880.250.31
0.19-0.4-0.070.090.430.25-0.510.350.030.15-0.14-0.560.290.0-0.26-0.030.49-0.39-0.27-0.120.14-0.310.060.21-0.02
-0.60.31-0.12-0.54-0.77-0.32-0.51-0.46-0.35-0.730.170.08-0.6-0.480.19-0.16-0.60.30.22-0.63-0.320.11-0.18-0.61-0.46
0.15-0.7-0.42-0.270.630.00.35-0.46-0.49-0.07-0.1-0.560.34-0.270.080.090.04-0.71-0.36-0.11-0.41-0.68-0.230.16-0.04
0.670.50.80.950.290.260.03-0.35-0.490.7-0.130.630.470.82-0.350.040.610.520.340.770.870.710.40.670.6
0.820.40.370.820.550.260.15-0.73-0.070.7-0.120.450.740.65-0.320.030.580.42-0.060.850.690.580.370.820.65
-0.110.11-0.24-0.23-0.140.76-0.140.17-0.1-0.13-0.120.29-0.28-0.12-0.6-0.910.040.110.68-0.04-0.010.030.64-0.2-0.12
0.420.70.580.57-0.040.28-0.560.08-0.560.630.450.290.160.65-0.33-0.30.180.710.510.620.580.770.470.380.51
0.940.20.360.660.840.130.29-0.60.340.470.74-0.280.160.42-0.280.080.620.21-0.140.610.590.360.210.950.58
0.660.210.860.890.450.30.0-0.48-0.270.820.65-0.120.650.42-0.30.110.660.240.280.780.790.450.360.660.74
-0.45-0.22-0.23-0.31-0.31-0.7-0.260.190.08-0.35-0.32-0.6-0.33-0.28-0.30.78-0.47-0.23-0.42-0.32-0.55-0.28-0.49-0.38-0.18
-0.05-0.260.180.140.06-0.75-0.03-0.160.090.040.03-0.91-0.30.080.110.78-0.09-0.25-0.550.0-0.11-0.18-0.610.030.05
0.74-0.030.610.710.730.610.49-0.60.040.610.580.040.180.620.66-0.47-0.09-0.010.380.570.80.190.620.730.62
0.321.00.320.4-0.290.0-0.390.3-0.710.520.420.110.710.210.24-0.23-0.25-0.010.20.350.50.970.310.30.25
0.110.190.380.21-0.020.71-0.270.22-0.360.34-0.060.680.51-0.140.28-0.42-0.550.380.20.220.380.230.760.050.21
0.770.330.570.850.520.37-0.12-0.63-0.110.770.85-0.040.620.610.78-0.320.00.570.350.220.680.530.440.760.76
0.780.480.820.880.440.390.14-0.32-0.410.870.69-0.010.580.590.79-0.55-0.110.80.50.380.680.670.510.770.62
0.50.960.50.62-0.10.07-0.310.11-0.680.710.580.030.770.360.45-0.28-0.180.190.970.230.530.670.370.480.41
0.40.310.250.360.230.880.06-0.18-0.230.40.370.640.470.210.36-0.49-0.610.620.310.760.440.510.370.340.47
1.00.280.580.830.820.250.21-0.610.160.670.82-0.20.380.950.66-0.380.030.730.30.050.760.770.480.340.71
0.710.240.610.710.540.31-0.02-0.46-0.040.60.65-0.120.510.580.74-0.180.050.620.250.210.760.620.410.470.71
Click cells to compare fundamentals

Apyx Medical Account Relationship Matchups

Apyx Medical balance sheet Accounts

201920202021202220232024 (projected)
Total Assets84.7M74.1M68.7M51.8M79.2M83.2M
Short Long Term Debt Total1.1M676K305K796K38.5M40.4M
Other Current Liab1.5M6.3M9.6M13.6M8.8M9.2M
Total Current Liabilities12.2M9.2M13.2M11.9M12.7M13.4M
Total Stockholder Equity71.3M63.7M53.7M37.6M26.7M24.4M
Property Plant And Equipment Net7.6M7.2M6.9M7.6M7.1M5.3M
Net Debt(57.7M)(41.2M)(30.6M)(9.4M)(5.2M)(5.4M)
Retained Earnings14.5M2.6M(12.6M)(35.7M)(54.4M)(51.7M)
Accounts Payable2.4M1.5M2.6M2.7M2.7M2.8M
Cash58.8M41.9M30.9M10.2M43.7M45.8M
Non Current Assets Total8.0M8.0M8.0M8.8M8.9M8.2M
Non Currrent Assets Other391K807K1.1M1.2M1.7M1.8M
Cash And Short Term Investments58.8M41.9M30.9M10.2M43.7M45.8M
Net Receivables9.2M17.3M21.2M18.2M14.1M14.8M
Common Stock Shares Outstanding34.1M34.2M34.3M34.5M34.6M22.4M
Liabilities And Stockholders Equity84.7M74.1M68.7M51.8M79.2M83.2M
Non Current Liabilities Total1.2M1.1M1.5M2.1M39.6M41.6M
Inventory5.1M4.1M6.8M11.8M9.9M5.3M
Other Current Assets3.6M2.8M1.9M2.7M2.7M2.9M
Other Stockholder Equity56.7M61.1M66.2M73.3M81.1M85.2M
Total Liab13.4M10.3M14.7M14.0M52.3M54.9M
Property Plant And Equipment Gross7.5M7.2M6.9M7.6M10.7M5.4M
Total Current Assets76.7M66.1M60.7M43.0M70.4M73.9M
Other Assets191K1.5M1.1M1.2M1.4M1.1M
Property Plant Equipment6.6M7.2M6.6M6.8M7.8M5.8M
Net Tangible Assets71.3M63.7M53.7M37.6M43.2M40.5M
Retained Earnings Total Equity14.5M2.6M(12.6M)(35.7M)(41.1M)(39.0M)
Capital Surpluse56.7M61.1M66.2M73.3M84.3M51.5M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Apyx Stock Analysis

When running Apyx Medical's price analysis, check to measure Apyx Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apyx Medical is operating at the current time. Most of Apyx Medical's value examination focuses on studying past and present price action to predict the probability of Apyx Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apyx Medical's price. Additionally, you may evaluate how the addition of Apyx Medical to your portfolios can decrease your overall portfolio volatility.